Assessment of restless legs syndrome—Methodological approaches for use in practice and clinical trials
Authors:
- 1 January 2007
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 22 (S18) , S485-S494
Abstract
The Restless Legs Syndrome (RLS) is a sensorimotor disorder that has only recently been extensively investigated by validated methods. Following the first presentation of diagnostic criteria by the International RLS Study Group in 1995, several methods were specifically developed for clinical trials in RLS or adapted from other areas of medicine and health sciences. We present a critical overview on validated methods to assess (1) severity of RLS symptoms [International RLS Rating Scale (IRLS), John Hopkins RLS Severity Scale (JHRLSSS), the RLS‐6 scales, and the investigtor‐based Clincial Global Impressions (CGI)]; (2) quality of life [RLS Quality of Life Instrument (RLS‐QLI), Hopkins RLS Quality of Life Questionnaire (RLSQoL), and the RLS Quality of Life Questionnaire (QoL‐RLS)]; (3) sleep disturbances and sudden onset of sleep; (4) sleep laboratory methods (polysomnography, limb activity monitoring by actigraphy) to evaluate sleep and periodic leg movements (including the “suggested immobilization test”); and (5) severity of augmentation (Augmentation Severity Rating Scale, ASRS). It is concluded that several validated methods are available to investigate the main features of RLS in practice and in clinical trials; however, further developments are needed to address new questions like the consequences of RLS on life functioning in areas such as ability to travel, days missed at work or impaired work performance. © 2007 Movement Disorder SocietyKeywords
This publication has 52 references indexed in Scilit:
- Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi‐center, randomized, active controlled trialMovement Disorders, 2007
- Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndromeSleep Medicine, 2006
- Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled studyMovement Disorders, 2004
- Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLSSleep Medicine, 2004
- Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double‐blind, placebo‐controlled pilot studyMovement Disorders, 2004
- Evaluating the quality of life of patients with restless legs syndromeClinical Therapeutics, 2004
- Bovine myoclonus: Model of human hyperekplexia (Startle disease)Movement Disorders, 2002
- Pergolide-associated ‘sleep attacks’ in a patient with restless legs syndromeSleep Medicine, 2002
- Toward a better definition of the restless legs syndromeMovement Disorders, 1995
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993